Access cutting-edge autism spectrum disorder treatment through this clinical trial at a research site in Lawrence. Study-provided care at no cost to qualified participants.
Access autism spectrum disorder specialists in Lawrence at no cost
This study follows strict safety protocols and ethical guidelines
All study-related autism spectrum disorder treatment provided free
This Phase 2 study examines the safety, tolerability, and preliminary efficacy of pimavanserin in individuals with Autism Spectrum Disorder. Male or female participants aged 16 to 40 years of age will be randomized to receive single doses of either placebo or pimavanserin in this randomized, placebo-controlled, cross-over designed study, followed by open label extension.
Sponsor: New York State Psychiatric Institute
Check if you qualify for this autism spectrum disorder clinical trial in Lawrence, KS
If you're searching for autism spectrum disorder treatment options in Lawrence, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lawrence research site is actively enrolling participants for this clinical trial. You'll receive care from experienced autism spectrum disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.